These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9125615)
1. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Dizon-Townson DS; Nelson LM; Jang H; Varner MW; Ward K Am J Obstet Gynecol; 1997 Apr; 176(4):883-6. PubMed ID: 9125615 [TBL] [Abstract][Full Text] [Related]
2. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617 [TBL] [Abstract][Full Text] [Related]
3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310 [TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702 [TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318 [TBL] [Abstract][Full Text] [Related]
6. The factor V Leiden mutation may predispose women to severe preeclampsia. Dizon-Townson DS; Nelson LM; Easton K; Ward K Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):902-5. PubMed ID: 8885745 [TBL] [Abstract][Full Text] [Related]
7. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561 [TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium. Yilmazer M; Kurtay G; Sonmezer M; Akar N Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875 [TBL] [Abstract][Full Text] [Related]
9. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751 [TBL] [Abstract][Full Text] [Related]
10. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG; Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593 [TBL] [Abstract][Full Text] [Related]
12. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484 [TBL] [Abstract][Full Text] [Related]
13. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. DeSancho MT; Berlus N; Christos PJ; Rand J Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699 [TBL] [Abstract][Full Text] [Related]
15. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987 [TBL] [Abstract][Full Text] [Related]
17. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427 [TBL] [Abstract][Full Text] [Related]
18. Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127-->a mutation in the thrombomodulin gene. Magdelaine A; Verdy E; Coulet F; Berkane N; Girot R; Uzan S; Soubrier F Blood Coagul Fibrinolysis; 2000 Dec; 11(8):761-5. PubMed ID: 11132655 [TBL] [Abstract][Full Text] [Related]
19. Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis. Andersen BS; Olsen J Thromb Res; 1998 May; 90(4):191-4. PubMed ID: 9692618 [TBL] [Abstract][Full Text] [Related]
20. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]